ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for smarter Trade smarter, not harder: Unleash your inner pro with our toolkit and live discussions.
Accolade Inc

Accolade Inc (ACCD)

3.44
0.12
( 3.61% )
Updated: 05:44:57

Professional-Grade Tools, for Individual Investors.

Key stats and details

Current Price
3.44
Bid
3.44
Offer
3.45
Volume
557,328
3.26 Day's Range 3.455
3.08 52 Week Range 15.36
Market Cap
Previous Close
3.32
Open
3.26
Last Trade
10
@
3.445
Last Trade Time
05:46:46
Financial Volume
US$ 1,862,117
VWAP
3.3412
Average Volume (3m)
1,364,846
Shares Outstanding
80,537,080
Dividend Yield
-
PE Ratio
-2.76
Earnings Per Share (EPS)
-1.24
Revenue
414.29M
Net Profit
-99.81M

About Accolade Inc

Accolade Inc offers technology-enabled solutions that help people better understand, navigate, and utilize the healthcare system and their workplace benefits. It generates revenue by providing personalized health guidance solutions to members. Accolade Inc offers technology-enabled solutions that help people better understand, navigate, and utilize the healthcare system and their workplace benefits. It generates revenue by providing personalized health guidance solutions to members.

Sector
Business Services, Nec
Industry
Business Services, Nec
Headquarters
Wilmington, Delaware, USA
Founded
-
Accolade Inc is listed in the Business Services sector of the NASDAQ with ticker ACCD. The last closing price for Accolade was US$3.32. Over the last year, Accolade shares have traded in a share price range of US$ 3.08 to US$ 15.36.

Accolade currently has 80,537,080 shares in issue. The market capitalisation of Accolade is US$267.38 million. Accolade has a price to earnings ratio (PE ratio) of -2.76.

ACCD Latest News

Accolade to Announce Fiscal Third Quarter 2025 Financial Results

SEATTLE, Dec. 16, 2024 (GLOBE NEWSWIRE) -- Accolade, Inc. (NASDAQ: ACCD) today announced that it will release fiscal third quarter 2025 financial results on Thursday, January 9, 2024 after the...

PeriodChangeChange %OpenHighLowAvg. Daily VolVWAP
1-0.04-1.149425287363.483.613.1712025803.35126865CS
4-0.26-7.027027027033.73.9253.1710663323.58513752CS
12-0.48-12.24489795923.924.553.0813648463.62134569CS
26-2.76-44.51612903236.26.413.0813170133.8457246CS
52-7.95-69.798068481111.3915.363.0810125355.98406765CS
156-19.93-85.280273855423.3727.743.089128679.27248237CS
260-31.56-90.17142857143565.253.0881237417.59822033CS

ACCD - Frequently Asked Questions (FAQ)

What is the current Accolade share price?
The current share price of Accolade is US$ 3.44
How many Accolade shares are in issue?
Accolade has 80,537,080 shares in issue
What is the market cap of Accolade?
The market capitalisation of Accolade is USD 267.38M
What is the 1 year trading range for Accolade share price?
Accolade has traded in the range of US$ 3.08 to US$ 15.36 during the past year
What is the PE ratio of Accolade?
The price to earnings ratio of Accolade is -2.76
What is the cash to sales ratio of Accolade?
The cash to sales ratio of Accolade is 0.66
What is the reporting currency for Accolade?
Accolade reports financial results in USD
What is the latest annual turnover for Accolade?
The latest annual turnover of Accolade is USD 414.29M
What is the latest annual profit for Accolade?
The latest annual profit of Accolade is USD -99.81M
What is the registered address of Accolade?
The registered address for Accolade is 251 LITTLE FALLS DRIVE, NEW CASTLE, WILMINGTON, DELAWARE, 19808
What is the Accolade website address?
The website address for Accolade is www.accolade.com
Which industry sector does Accolade operate in?
Accolade operates in the BUSINESS SERVICES, NEC sector

Movers

View all
  • Most Active
  • % Gainers
  • % Losers
SymbolPriceVol.
MYSZMy Size Inc
US$ 4.38
(224.44%)
113.48M
EDBLEdible Garden AG Inc
US$ 0.296
(103.58%)
270.87M
NVNINVNI Group Ltd
US$ 5.2943
(98.29%)
36.64M
TPICTPI Composites Inc
US$ 2.03
(66.39%)
11.11M
HSDTHelius Medical Technologies Inc
US$ 0.7702
(60.46%)
111.64M
CYNCYNGN Inc
US$ 0.4287
(-73.37%)
21.64M
MTEMMolecular Templates Inc
US$ 0.145
(-58.57%)
6.73M
PRFXPainReform Ltd
US$ 4.82
(-56.81%)
2.29M
GALTGalectin Therapeutics Inc
US$ 0.901
(-54.95%)
7.69M
FNGRFingerMotion Inc
US$ 1.1701
(-41.50%)
2.82M
APTOAptose Biosciences Inc
US$ 0.251501
(47.77%)
289.95M
EDBLEdible Garden AG Inc
US$ 0.296
(103.58%)
270.87M
TNXPTonix Pharmaceuticals Holding Corporation
US$ 0.5961
(4.58%)
226.72M
RGTIRigetti Computing Inc
US$ 9.5188
(27.43%)
168.34M
NVDANVIDIA Corporation
US$ 133.90
(2.46%)
156.63M

ACCD Discussion

View Posts
EarningsCentral EarningsCentral 2 months ago
👍️0
Monksdream Monksdream 3 months ago
ACCD under $4
👍️0
Monksdream Monksdream 6 months ago
ACCD new 52 week low
👍️0
Monksdream Monksdream 1 year ago
That awful Cathie Wood bought more shares

👍️0
Monksdream Monksdream 1 year ago
ACCD That awful Cathie Wood bought shares.
Accolade Inc NASDAQ: ACCD

GoSymbol lookup
Health Care : Health Care Providers & Services | Small Cap BlendCompany profile
Accolade, Inc. provides personalized, technology-enabled solutions that help people understand, navigate, and utilize the healthcare system and their workplace benefits. Its customers are primarily employers that deploy Accolade solutions in order to provide employees and their families with a single place to turn for their health, healthcare, and benefits needs. It also offers medical opinion services to commercial customers and virtual primary care and mental health support. Its platform, True Health Engine, combines open, cloud-based intelligent technology with multimodal support from a team of empathetic and knowledgeable Accolade Health Assistants and clinicians, including registered nurses, physician medical directors, pharmacists, behavioral health specialists, women’s health specialists, case management specialists, expert medical opinion providers, and virtual primary care physicians. Its offerings include Accolade Expert MD, Accolade Care, Plus and Connect and Accolade One.
👍️0
forthepeach forthepeach 3 years ago
Will this help their stock price?
https://finance.yahoo.com/news/accolade-expands-mental-health-integrated-130000009.html
👍️0
swampboots swampboots 3 years ago
ACCD down 50% will lose big customer end of year and always has loses on increased revenue, spends a ton on research and dev.
👍️0
crudeoil24 crudeoil24 3 years ago
Accolade Sees Q4 Sales $90M-$93M vs $97.71M Est., Raises FY22 Sales Guidance From $303M-$307M To $306M-$309M vs $306.34M Est.
👍️0
crudeoil24 crudeoil24 3 years ago
Accolade Inc. is a provider of personalized, technology-enabled solutions that helps people to understand, navigate, and utilize the healthcare system and their workplace benefits. The Company’s customers are primarily employers that deploy Accolade in order to provide employees and their families members a single place to turn for their health, healthcare, and benefits needs. Its platform combines open, cloud-based intelligent technology with multimodal support from a team of empathetic and knowledgeable Accolade Health Assistants and clinicians, including nurses, physician medical directors, and behavioral health specialists. The Company leverages its integrated capabilities, connectivity with providers and the healthcare ecosystem, and longitudinal data to engage across the member population. Its offerings are: Accolade Total Benefits, Accolade Total Care, Accolade Total Health and Benefits, Accolade Boost, the Trusted Supplier Program, and Mental Health Integrated Care solutions.
👍️0

Your Recent History

Delayed Upgrade Clock